يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"Cheung, S.Y. Amy"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://wrap.warwick.ac.uk/173374/1/engineering-160823-wrap--clin_pharma_and_therapeutics_-_2023_-_musuamba.pdfTest; Musuamba Tshinanu, Flora, Cheung, S.Y. Amy, Colin, Pieter, Davies, Elin H., Barret, Jeffrey S., Pappalardo, Francesco, Chappell, Michael J., Dogne, Jean‐Michel, Ceci, Adriana, Della Pasqua, Oscar and Rusten, Ine S. (2023) Moving towards a question‐centric approach for regulatory decision‐making in the context of drug assessment. Clinical Pharmacology & Therapeutics, 114 (1). pp. 41-50. doi:10.1002/cpt.2856 ISSN 1532-6535.

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: https://orca.cardiff.ac.uk/id/eprint/128328/1/Capivasertib%20%28AZD5363%29,%20an%20AKT%20inhibitor,%20rapidly%20and%20effectively%20targets%20key%20AKT%20pathway%20and%20proliferation%20biomarkers-%20the%20STAKT%20pre-surgical%20breast%20cancer%20study.pdfTest; Robertson, John F.R., Coleman, Robert E., Cheung, Kwok-Leung, Evans, Abigail, Holcombe, Chris, Skene, Anthony, Rea, Daniel, Ahmed, Samreen, Jahan, Ali, Horgan, Kieran, Rauchhaus, Petra, Littleford, Roberta, Cheung, S.Y. Amy, Cullberg, Marie, de Bruin, Elza C., Koulai, Loumpiana, Lindemann, Justin P. O., Pass, Martin, Rugman, Paul, Schiavon, Gaia, Deb, Rahul, Finlay, Pauline, Foxley, Andrew and Gee, Julia M.W. https://orca.cardiff.ac.uk/view/cardiffauthors/A055751U.htmlTest orcid:0000-0001-6483-2015 orcid:0000-0001-6483-2015 2020. Proliferation and AKT activity biomarker analyses after Capivasertib (AZD5363) treatment of patients with ER+ invasive breast cancer (STAKT). Clinical Cancer Research 26 (7) , pp. 1574-1585. 10.1158/1078-0432.CCR-19-3053 https://doi.org/10.1158/1078-0432.CCR-19-3053Test file https://orca.cardiff.ac.uk/id/eprint/128328/1/Capivasertib%20%28AZD5363%29,%20an%20AKT%20inhibitor,%20rapidly%20and%20effectively%20targets%20key%20AKT%20pathway%20and%20proliferation%20biomarkers-%20the%20STAKT%20pre-surgical%20breast%20cancer%20study.pdfTest

  10. 10
    دورية أكاديمية

    مصطلحات موضوعية: Q Science

    وصف الملف: application/pdf

    العلاقة: https://kar.kent.ac.uk/63859/1/Banerji%20et%20al%202017%20R2-Merged%20manuscript%20and%20Figures-Post%20decision-accepted.pdfTest; https://kar.kent.ac.uk/63859/2/Banerji%20et%20al%202017%20R2-Supplementary%20data_.pdfTest; https://kar.kent.ac.uk/63859/3/Banerji%20et%20al%202017%20R2-Supplementary%20Table.docx.pdfTest; Banerji, Udai, Dean, Emma J., Pérez-Fidalgo, J. Alejandro, Batist, Gerald, Bedard, Philippe L., You, Benoit, Westin, Shannon N., Kabos, Peter, Garrett, Michelle D., Tall, Mathew, and others. Ambrose, Helen, Barrett, J. Carl, Carr, T. Hedley, Cheung, S.Y. Amy, Corcoran, Claire, Cullberg, Marie, Davies, Barry R., de Bruin, Elza C., Elvin, Paul, Foxley, Andrew, Lawrence, Peter, Lindemann, Justin P.O., Maudsley, Rhiannon, Pass, Martin, Rowlands, Vicky, Rugman, Paul, Schiavon, Gaia, Yates, James, and Schellens, Jan H.M. (hide) (2018) A Phase 1 open-label study to identify a dosing regimen of the pan-AKT inhibitor AZD5363 for evaluation in solid tumors and in PIK3CA-mutated breast and gynecologic cancers. Clinical Cancer Research, 24 (9). pp. 2050-2059. ISSN 1078-0432. E-ISSN 1557-3265. (doi:10.1158/1078-0432.CCR-17-2260 ) (KAR id:63859 )